Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma
- PMID: 15953005
- DOI: 10.1111/j.1365-2141.2005.05525.x
Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma
Abstract
There is strong evidence that altered immunological function entails an increased risk of lymphoma, although the current knowledge of aetiological factors for lymphomas is limited. The CTLA4 gene encodes a receptor that provides a negative signal to the T-cell once an immune response is initiated and completed. We analysed the 2q33 chromosomal region harbouring CD28, CTLA4 and ICOS genes, which are closely linked and have related functions in immune regulation, for association in 100 non-Hodgkin's lymphoma (NHL) patients and in 128 healthy controls; both groups originated from Sardinia. There was a strong association of the CTLA4 49A and the 3'-untranslated region (AT)(82) alleles with NHL [odds ratio (OR) = 2, 95% confidence interval (CI) = 1.2-3.2, and OR = 1.6, 95% CI = 1.1-2.4 respectively]. CTLA4-318C:49A:(AT)(82) was the most represented haplotype in the studied population and was associated with NHL (P = 0.0029, OR = 1.76, 95% CI = 1.2-2.5). Strong linkage disequilibrium was detected between CD28, CTLA4 and ICOS and a 'common' haplotype was found very frequently among NHLs. However, no independent association between CD28, ICOS, D2S72 markers and NHL was observed. Our findings enable CTLA4 from adjacent functionally related genes as the true causative risk gene for NHL susceptibility at least in Sardinian patients.
Similar articles
-
Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study.Hum Mol Genet. 2006 Nov 1;15(21):3195-205. doi: 10.1093/hmg/ddl395. Epub 2006 Sep 25. Hum Mol Genet. 2006. PMID: 17000707
-
Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease.Tissue Antigens. 2004 Nov;64(5):593-9. doi: 10.1111/j.1399-0039.2004.00312.x. Tissue Antigens. 2004. PMID: 15496203
-
No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.Scand J Gastroenterol. 2006 May;41(5):586-91. doi: 10.1080/00365520500377870. Scand J Gastroenterol. 2006. PMID: 16638702
-
IMGT Colliers de Perles and IgSF domain standardization for T cell costimulatory activatory (CD28, ICOS) and inhibitory (CTLA4, PDCD1 and BTLA) receptors.Dev Comp Immunol. 2007;31(10):1050-72. doi: 10.1016/j.dci.2007.01.008. Epub 2007 Mar 5. Dev Comp Immunol. 2007. PMID: 17391759 Review.
-
Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease.Ann Hum Genet. 2002 Mar;66(Pt 2):125-37. doi: 10.1017/S0003480002001021. Ann Hum Genet. 2002. PMID: 12174216 Review.
Cited by
-
Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.Front Immunol. 2021 Jan 14;11:606721. doi: 10.3389/fimmu.2020.606721. eCollection 2020. Front Immunol. 2021. PMID: 33519815 Free PMC article. Review.
-
The expression, function, and clinical relevance of B7 family members in cancer.Cancer Immunol Immunother. 2012 Aug;61(8):1327-41. doi: 10.1007/s00262-012-1293-6. Epub 2012 Jun 14. Cancer Immunol Immunother. 2012. PMID: 22695874 Free PMC article. Review.
-
Association between the Cytotoxic T-lymphocyte antigen 4 +49G > A polymorphism and cancer risk: a meta-analysis.BMC Cancer. 2010 Oct 4;10:522. doi: 10.1186/1471-2407-10-522. BMC Cancer. 2010. PMID: 20920330 Free PMC article.
-
Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.Tumour Biol. 2014 Apr;35(4):3627-39. doi: 10.1007/s13277-013-1480-x. Epub 2013 Dec 5. Tumour Biol. 2014. PMID: 24307627
-
Associations between CTLA-4 +49 A/G (rs231775) polymorphism and cancer risk: a meta-analysis based on 52 case-control studies.Int J Clin Exp Med. 2015 May 15;8(5):6835-51. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26221222 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources